BioClone Ltd. is a global organisation bringing together biopharmaceutical companies for the development, production and approval of future biologically based drugs and delivery devices. Based in London we provide training, consulting and project management services as well as access to international expertise in biotechnological analysis, transport, cell banking and production throughout development, pre-clinical to clinical trials and pharmacovigilance. In addition we assist in developing specifications and procedures to meet the regulatory requirements and gain approval from statutory regulatory authorities including the EMA, FDA and DRA. CONNECT PROMOTE SUCCEED
| Website | http://www.bioclone.co.uk |
| Revenue | $1.4 million |
| Employees | 2 (2 on RocketReach) |
| Founded | 2015 |
| Phone | +44 20 3755 3672 |
| Industry | Biotechnology Research |
| Keywords | Biotechnology, Biopharmaceutical, Drug Development, Pharmaceutical Research, Biological Drugs, Life Sciences, Drug Discovery, Drug Delivery, Bioprocessing, Biologics Manufacturing, Clinical Development, Process Development, Pharmaceutical Consulting, Pharma Consulting, Regulatory Affairs, Pharmaceutical Training, Pharmaceutical Services, Pharmaceutical Production, Contract Manufacturing, Drug Approval |
| Competitors | Merck Group, Thermo Fisher Scientific, Bio-Rad Magyarország Kft., abcam, MilliporeSigma, Genentech, Lonza, Fisher Scientific, QIAGEN +33 more (view full list) |
Looking for a particular BioClone Ltd. employee's phone or email?
The BioClone Ltd. annual revenue was $1.4 million in 2026.
Andrew Kenyon is the CEO of BioClone Ltd..
2 people are employed at BioClone Ltd..